Publication | Closed Access

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India

Cancer EpidemiologyMedicineEgfr-tyrosine Kinase InhibitorsPathologyBronchial NeoplasmCancer TreatmentClinical PredictorsOncologyRadiation OncologyLung CancerMolecular Oncology